Literature DB >> 28556361

Skin involvement as the first symptom of rapidly progressive ALK-positive systemic anaplastic large cell lymphoma.

X Yu1, J Zhang1, K Xu2, M Li1, Z Yao1.   

Abstract

Systemic anaplastic large cell lymphomas (sALCLs) comprise a heterogeneous group of relatively rare T-cell non-Hodgkin lymphomas that are characterized by CD30 expression. Anaplastic lymphoma kinase (ALK)-positive ALCL is a type of sALCL that commonly involves lymph nodes and extranodal sites. Skin involvement usually presents as tumours, nodules and ulcers. We describe an unusual case of ALK-positive ALCL in an 11-year-old Chinese boy, who initially presented with skin eruption with rapid progression and poor prognosis. This case emphasizes the value of clinical factors to predict the prognosis of ALK-positive sALCL, and we recommend close collaboration between dermatologists, pathologists and haematologists/oncologists to assure the correct diagnosis and treatment.
© 2017 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28556361     DOI: 10.1111/ced.13146

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  2 in total

1.  Rare Presentation of Hypoglycemia in a Patient with Anaplastic Large-Cell Lymphoma.

Authors:  Raed Aldahash
Journal:  Case Rep Endocrinol       Date:  2021-12-02

Review 2.  Anaplastic Lymphoma Kinase in Cutaneous Malignancies.

Authors:  Severine Cao; Vinod E Nambudiri
Journal:  Cancers (Basel)       Date:  2017-09-12       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.